Search results
Biogen and Ionis halt ALS drug development after trial setback By Investing.com
Investing.com· 32 minutes agoBiogen Inc. (NASDAQ:BIIB) and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) have announced the...
Biogen walks away from Ionis-partnered ALS, Angelman prospects after peek at clinical data
FierceBiotech· 1 hour agoBiogen’s CEO may have been celebrating “turning a corner” last month, but it looks like the...
Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic...
WFRV 5 Green Bay· 3 hours agoIonis Pharmaceuticals, Inc. (Nasdaq: IONS) and Biogen Inc. (Nasdaq: BIIB) announced the decision to terminate development of BIIB105 (ION541) an investigational antisense ...
Biogen, Ionis to discontinue development of experimental ALS drug
Reuters via Yahoo News· 3 hours agoShares of Biogen and Ionis were each down nearly 2% in premarket trading. This marks another setback...
Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
Zacks via Yahoo Finance· 22 hours agoBiogen (BIIB) and Eisai start the rolling submission of a biologics license application to the FDA...
Biogen Stock Continues Its 24% Sprint On A Twist In Alzheimer's Treatment
Investor's Business Daily· 18 hours agoBiogen stock jumped early Wednesday after the Food and Drug Administration gave its Eisai-partnered...
Analyst Report: Biogen Inc
Argus Research via Yahoo Finance· 21 hours agoBiogen is a biotech company that develops, manufactures, and sells therapies for treating neurological and neurodegenerative diseases. The company is the market leader in ...
New Outlook On Biogen Inc – Stocks Register
Stocks Register· 5 days agoBiogen Inc (NASDAQ:BIIB) price on Friday, May 10, fall -0.56% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $221.50. A look ...
Eisai sets new revenue target for Alzheimer’s drug Leqembi
BioPharma Dive via Yahoo Finance· 1 day agoThe annual forecast, which comes as Eisai and Biogen have begun submitting a more convenient form of...
Is Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?
Investor's Business Daily· 23 hours agoEli Lilly stock yo-yoed recently after announcing the Food and Drug Administration has scheduled an...
